N Ammon1, S Mason2, J M Corkery3. 1. Picturing Health, PO Box 122, Zomba, Malawi. Electronic address: nadineammon77@gmx.de. 2. Department of Pharmacy, Pharmacology and Postgraduate Medicine, University of Hertfordshire, College Lane Campus, Hatfield, Hertfordshire, AL10 9AB, UK. Electronic address: s.mason3@herts.ac.uk. 3. Department of Pharmacy, Pharmacology and Postgraduate Medicine, University of Hertfordshire, College Lane Campus, Hatfield, Hertfordshire, AL10 9AB, UK. Electronic address: j.corkery@herts.ac.uk.
Abstract
OBJECTIVES: Eighty-two percent of human immunodeficiency virus (HIV)-positive adolescents live in Sub-Saharan Africa (SSA). Despite the availability of antiretroviral therapy (ART), adherence levels are suboptimal, leading to poor outcomes. This systematic review investigated factors impacting ART adherence among adolescents in SSA, including religious beliefs and intimate relationships. METHODS: A systematic review was conducted between June and August 2016 using eight electronic databases, including Cochrane and PubMed. Published, ongoing and unpublished research, conducted in SSA from 2004 to 2016, was identified and thematic analysis was used to summarise findings. RESULTS: Eleven studies from eight SSA countries, published in English between 2011 and 2016, reported on factors impacting ART adherence among adolescents living with HIV (ALHIV). Forty-four barriers and 29 facilitators to adherence were identified, representing a complex web of factors. The main barriers were stigma, ART side-effects, lack of assistance and forgetfulness. Facilitators included caregiver support, peer support groups and knowledge of HIV status. CONCLUSIONS: Stigma reflects difficult relations between ALHIV and their HIV-negative peers and adults. Most interventions target only those with HIV, suggesting a policy shift towards the wider community could be beneficial. Recommendations include engaging religious leaders and schools to change negative societal attitudes. Limitations of the review include the urban settings and recruitment of predominantly vertically infected participants in most included studies. Therefore, the findings cannot be extrapolated to ALHIV residing in rural locations or horizontally infected ALHIV, highlighting the need for further research in those areas.
OBJECTIVES: Eighty-two percent of human immunodeficiency virus (HIV)-positive adolescents live in Sub-Saharan Africa (SSA). Despite the availability of antiretroviral therapy (ART), adherence levels are suboptimal, leading to poor outcomes. This systematic review investigated factors impacting ART adherence among adolescents in SSA, including religious beliefs and intimate relationships. METHODS: A systematic review was conducted between June and August 2016 using eight electronic databases, including Cochrane and PubMed. Published, ongoing and unpublished research, conducted in SSA from 2004 to 2016, was identified and thematic analysis was used to summarise findings. RESULTS: Eleven studies from eight SSA countries, published in English between 2011 and 2016, reported on factors impacting ART adherence among adolescents living with HIV (ALHIV). Forty-four barriers and 29 facilitators to adherence were identified, representing a complex web of factors. The main barriers were stigma, ART side-effects, lack of assistance and forgetfulness. Facilitators included caregiver support, peer support groups and knowledge of HIV status. CONCLUSIONS: Stigma reflects difficult relations between ALHIV and their HIV-negative peers and adults. Most interventions target only those with HIV, suggesting a policy shift towards the wider community could be beneficial. Recommendations include engaging religious leaders and schools to change negative societal attitudes. Limitations of the review include the urban settings and recruitment of predominantly vertically infected participants in most included studies. Therefore, the findings cannot be extrapolated to ALHIV residing in rural locations or horizontally infected ALHIV, highlighting the need for further research in those areas.
Authors: Carolyn M Audet; Mariah Pettapiece-Phillips; Yuqi Tian; Bryan E Shepherd; Sten H Vermund; Jose Salato Journal: PLoS One Date: 2022-06-28 Impact factor: 3.752
Authors: Uzaib Saya; Sarah MacCarthy; Barbara Mukasa; Peter Wabukala; Lillian Lunkuse; Zachary Wagner; Sebastian Linnemayr Journal: BMC Public Health Date: 2022-05-27 Impact factor: 4.135
Authors: I Marion Sumari-de Boer; Kennedy M Ngowi; Tolbert B Sonda; Francis M Pima; Lyidia V Masika Bpharm; Mirjam A G Sprangers; Peter Reiss; Blandina T Mmbaga; Pythia T Nieuwkerk; Rob E Aarnoutse Journal: J Acquir Immune Defic Syndr Date: 2021-08-15 Impact factor: 3.771
Authors: Lillian B Brown; Laura B Balzer; Jane Kabami; Dalsone Kwarisiima; Norton Sang; James Ayieko; Yiqun Chen; Gabriel Chamie; Edwin D Charlebois; Carol S Camlin; Craig R Cohen; Elizabeth Bukusi; Moses R Kamya; James Moody; Diane V Havlir; Maya L Petersen Journal: J Acquir Immune Defic Syndr Date: 2020-01-01 Impact factor: 3.771
Authors: Babafemi O Taiwo; Kehinde M Kuti; Lisa M Kuhns; Olayinka Omigbodun; Olutosin Awolude; Adedotun Adetunji; Baiba Berzins; Patrick Janulis; Amy K Johnson; Ogochukwu Okonkwor; Bibilola D Oladeji; Abigail Muldoon; Olubusuyi M Adewumi; Paul Amoo; Hannah Atunde; Bill Kapogiannis; Robert Garofalo Journal: J Acquir Immune Defic Syndr Date: 2021-08-01 Impact factor: 3.771
Authors: Rachel Brathwaite; Fred M Ssewamala; Torsten B Neilands; Moses Okumu; Massy Mutumba; Christopher Damulira; Proscovia Nabunya; Samuel Kizito; Ozge Sensoy Bahar; Claude A Mellins; Mary M McKay Journal: J Int AIDS Soc Date: 2021-06 Impact factor: 6.707